lensar.com - LNSR Company Value to Revenue Ratio

Public company logo of LENSAR (LNSR)

Does the growth in laser interventions ensure the financial stability of LENSAR, Inc. (LNSR)? LENSAR, Inc. (LNSR) is scaling sales of its ALLY platform in the US and Europe, expanding its presence in ophthalmology. Success depends on insurance payouts and the rate of clinic upgrades. The firm's valuation via the EV/Sales multiple visualizes the business value relative to revenue excluding debt, where the value 1005.33 shows the latest figure.

LNSR LENSAR, Inc.: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

LNSR (LENSAR, Inc): analytical breakdowns and indicator data

Fundamental valuation:LENSAR, Inc. LNSR
Mass-produced product of LENSAR Inc.

Evaluating capitalization efficiency is critical for identifying the fundamental leaders of the sector. This indicator compares the total business value with sales volume, excluding the impact of debt load to reveal the net market premium. For LENSAR, Inc. (LNSR), rising demand for ALLY systems and increased fees directly impact this denominator. Analyzing the enterprise value-to-revenue ratio determines whether international prospects are already priced in. Any deviation of this chart from average values will indicate either overvaluation or hidden growth potential.

Competitor analysis for LENSAR, Inc.

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|AVITA Medical Inc - Company Value to Revenue|EV/Sales Multiple Profound Medical Corporation PROF|Baird Medical Investment Holdings - EV/Sales Multiple|Total Company Value-to-Revenue Ratio EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume ICCM (IceCure Medical, Ltd.)|Enterprise Value-to-Revenue Ratio pulmonx.com|Company Value to Revenue TELA Bio, Inc. (TELA)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)